RU96114427A - PHARMACEUTICAL COMPOSITION WITH HEPATOPROTECTIVE ACTION - Google Patents

PHARMACEUTICAL COMPOSITION WITH HEPATOPROTECTIVE ACTION

Info

Publication number
RU96114427A
RU96114427A RU96114427/14A RU96114427A RU96114427A RU 96114427 A RU96114427 A RU 96114427A RU 96114427/14 A RU96114427/14 A RU 96114427/14A RU 96114427 A RU96114427 A RU 96114427A RU 96114427 A RU96114427 A RU 96114427A
Authority
RU
Russia
Prior art keywords
pharmaceutical composition
hepatoprotective
vitamins
sorbitol
talc
Prior art date
Application number
RU96114427/14A
Other languages
Russian (ru)
Other versions
RU2111747C1 (en
Inventor
С.Я. Скачилова
Г.А. Ермакова
Л.А. Радкевич
Н.В. Остапчук
И.Б. Коршунов
Л.Н. Сернов
И.И. Тюляев
В.А. Быков
А.П. Зуев
Б.И. Демченко
П.М. Лян
Зу Так Бак
Гил Зу Юн
Н.Э. Пынько
Original Assignee
Всероссийский научный центр по безопасности биологически активных веществ (ВНЦБАВ)
С.Я. Скачилова
Л.А. Радкевич
Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин"
Filing date
Publication date
Application filed by Всероссийский научный центр по безопасности биологически активных веществ (ВНЦБАВ), С.Я. Скачилова, Л.А. Радкевич, Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" filed Critical Всероссийский научный центр по безопасности биологически активных веществ (ВНЦБАВ)
Priority to RU96114427A priority Critical patent/RU2111747C1/en
Priority claimed from RU96114427A external-priority patent/RU2111747C1/en
Application granted granted Critical
Publication of RU2111747C1 publication Critical patent/RU2111747C1/en
Publication of RU96114427A publication Critical patent/RU96114427A/en

Links

Claims (2)

1. Фармацевтическая композиция, обладающая гепатопротекторным действием, включающая в качестве активного начала производное аминокислоты и целевые добавки, отличающаяся тем, что в качестве производного аминокислоты она содержит эффективное количество соли N-ацетил-L-глутаминовой кислоты с 2-(диметиламино)этанолом.1. A pharmaceutical composition having a hepatoprotective effect, comprising as an active principle an amino acid derivative and targeted supplements, characterized in that as an amino acid derivative it contains an effective amount of a salt of N-acetyl-L-glutamic acid with 2- (dimethylamino) ethanol. 2. Фармацевтическая композиция по п.1, отличающаяся тем, что она дополнительно содержит смесь витаминов гепатопротекторного действия, а в качестве целевых добавок - наполнители, включающие аэросил, крахмал, тальк, стеарат магния и сорбит, при следующем соотношении компонентов, мас.%:
Активное начало - 9 - 11
Смесь витаминов - 13 - 15
Аэросил - 15 - 25
Крахмал - 20 - 55
Тальк - 1 - 5
Стеарат магния - 3 - 8
Сорбит - 1 - 16
3. Фармацевтическая композиция по п.1, отличающаяся тем, что она представляет собой порошок, раствор, таблетки, драже или заключена в капсулы.2. The pharmaceutical composition according to claim 1, characterized in that it additionally contains a mixture of vitamins of hepatoprotective action, and as targeted additives - fillers, including aerosil, starch, talc, magnesium stearate and sorbitol, in the following ratio of components, wt.%:
Active start - 9 - 11
A mixture of vitamins - 13 - 15
Aerosil - 15 - 25
Starch - 20 - 55
Talc - 1 - 5
Magnesium stearate - 3 - 8
Sorbitol - 1 - 16
3. The pharmaceutical composition according to claim 1, characterized in that it is a powder, solution, tablets, pills or enclosed in capsules.
RU96114427A 1996-07-31 1996-07-31 Pharmaceutical composition showing hepatoprotective effect RU2111747C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU96114427A RU2111747C1 (en) 1996-07-31 1996-07-31 Pharmaceutical composition showing hepatoprotective effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU96114427A RU2111747C1 (en) 1996-07-31 1996-07-31 Pharmaceutical composition showing hepatoprotective effect

Publications (2)

Publication Number Publication Date
RU2111747C1 RU2111747C1 (en) 1998-05-27
RU96114427A true RU96114427A (en) 1998-12-10

Family

ID=20183403

Family Applications (1)

Application Number Title Priority Date Filing Date
RU96114427A RU2111747C1 (en) 1996-07-31 1996-07-31 Pharmaceutical composition showing hepatoprotective effect

Country Status (1)

Country Link
RU (1) RU2111747C1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2453310C1 (en) * 2010-12-09 2012-06-20 Открытое акционерное общество "Всероссийский научный центр по безопасности биологически активных веществ" (ОАО "ВНЦ БАВ") Agent possessing neuroprotective action in ischemic cerebral injury and hypoxia, representing magnesium 2-aminoethanesulfonate, pharmaceutical compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2453310C1 (en) * 2010-12-09 2012-06-20 Открытое акционерное общество "Всероссийский научный центр по безопасности биологически активных веществ" (ОАО "ВНЦ БАВ") Agent possessing neuroprotective action in ischemic cerebral injury and hypoxia, representing magnesium 2-aminoethanesulfonate, pharmaceutical compositions

Similar Documents

Publication Publication Date Title
EP1435240A3 (en) Solid oral dosage form comprising a combination of methformin and glibenclamide
GB9808796D0 (en) Antithrombotic agents
ATE279186T1 (en) SUSTAINED-RELEASE PHARMACEUTICAL FORM CONTAINING TRAMADOL ACCHARINATE
AR028299A1 (en) A PHARMACEUTICAL COMPOSITION THAT INCLUDES NATEGLINIDA, A PROCESS FOR ITS PREPARATION AND THE USE OF SUCH COMPOSITION FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF METABOLIC DISORDERS, ESPECIALLY DIABETES, OR A DISEASE OR CONDITION ASSOCIATED WITH DIABETY.
RU93051537A (en) ORAL DOSAGE FORM
PT1007006E (en) FORMULATION OF CEFADROXIL MONO-HYDRATE TABLET
KR960000217A (en) L-carnitine salts and compositions containing them
ATE73656T1 (en) ANTI-INFLAMMATORY MEDICATION CONTAINING IBUPROFEN WHICH IN AQUEOUS SOLUTION HAS NO BITTER TASTE, LARYNX IRRITATION AND INTESTINAL TOXICITY.
TW225536B (en)
SK103296A3 (en) Film coated tablet of paracetamol and domperidone
RU96116411A (en) QUICKLY DISPERSABLE READY-FORMED DRUG FORM TRAMADOL OR TRAMADOL SALT
CA2366841A1 (en) Tolperisone-containing pharmaceutical preparation for oral administration
IT1270239B (en) SOLID PHARMACEUTICAL COMPOSITION CONTAINING ACID (S) -2- (4- ISOBUTYLPHENYL) PROPIONIC AS ACTIVE INGREDIENT
EA200200019A1 (en) COMPOSITION CONTAINING ALKALINE SPHINGOMIELINASE FOR APPLICATION AS A DIET PREPARATION, FOOD SUPPLEMENT OR PHARMACEUTICAL PRODUCT
RU96114427A (en) PHARMACEUTICAL COMPOSITION WITH HEPATOPROTECTIVE ACTION
RU92004569A (en) PHARMACEUTICAL PRODUCT OF ANTI-STRESS, STRESS-PROTECTIVE AND NOOTROPIC ACTION
RU2007105450A (en) TREATMENT AND PREVENTION OF DISEASES AND INFECTIONS OF PIGS AND Poultry
RU2002119033A (en) Means for the normalization of functional disorders that occur in the premenopausal and menopausal period
KR970061084A (en) How to promote chicken development
RU98105696A (en) MEANS FOR TREATMENT AND PREVENTION OF DISEASES OF THE ORAL CAVITY
RU2003132049A (en) PHARMACEUTICAL COMPOSITION Possessing Cerebrovasodilating and Nootropic Activity
RU2002123278A (en) External analgesic and anti-contracting drug
RU2002107913A (en) Pharmaceutical composition of thyroid hormone
RU93004775A (en) NEW DIAROMATIC COMPOUNDS, HAVING ANTIATHEROCLEROTIC ACTIVITY, THEIR USE, PHARMACEUTICAL COMPOSITIONS
RU98115372A (en) MEDICINE "DYNALGIN"